Skip to main content
. 2014 Oct 7;16(11):1230–1240. doi: 10.1002/ejhf.170

Table 4.

Associations of diuretic response with selected outcomes

Unadjusted Adjusted


Outcome Contrast Measure of association (95% CI) P-value Measure of association (95% CI) P-value
Dyspnoea VAS AUC to day 5a 0.0002 0.0001
T2 vs. T1 −355.944 (−751.753, 39.866) −319.370 (−645.481, 6.740)
T3 vs. T1 −855.674 (−1265.072, −446.276) −749.944 (−1096.009, −403.879)
CV death or HF/RF rehospitalization through day 60b <0.0001 0.0005
T2 vs. T1 1.122 (0.702, 1.794) 0.919 (0.566, 1.494) .
T3 vs. T1 2.735 (1.806, 4.142) 1.855 (1.195, 2.879) .
CV death through day 180c 0.1323 0.5069
T2 vs. T1 0.865 (0.502, 1.490) 0.948 (0.533, 1.689) .
T3 vs. T1 1.417 (0.856, 2.347) 1.273 (0.722, 2.244) .

T1 = first tertile (≤ −0.75 kg/40 mg), T2 = second tertile (> − 0.75 to ≤ −0.22 kg/40 mg), T3 = third tertile (> −0.22 kg/40 mg).

AUC, area under the curve; CI, confidence interval; CV, cardiovascular; HF, heart failure; RF, renal failure; VAS, visual analogue scale.

a

Measure of association is mean change from linear regression model. Adjusted for age, weight, hypertension, mitral regurgitation, history of atrial fibrillation or flutter, USA-like region, dyspnoea on exertion, body temperature, troponin T, baseline dyspnoea VAS score, uric acid, alkaline phosphatase, and sodium.

b

Measure of association is hazard ratio from Cox regression model. Adjusted for white race; NYHA class 30 days prior; systolic blood pressure; respiratory rate; number of HF hospitalizations in past year; orthopnoea; asthma, bronchitis, or COPD; hyperthyroid; lymphocyte %; blood urea nitrogen; phosphate; sodium; and total protein.

c

Measure of association is hazard ratio from Cox regression model. Adjusted for USA-like region, systolic blood pressure, orthopnoea, angina, hyperthyroid, mitral regurgitation, atrial fibrillation or flutter at screening, white blood cell count, lymphocyte %, blood urea nitrogen, sodium, potassium, calcium, total protein, troponin T, and NT-proBNP.